Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OZ Biosciences develops proprietary molecular delivery platforms—such as Magnetofection™, Lipofection, Polyfection—for efficient transfection/transduction of nucleic acids and proteins into cells. Their technologies are widely used by academic labs and pharmaceutical companies for basic research, drug discovery support, genome editing experiments including CRISPR/Cas9 applications. They also offer custom services such as mRNA synthesis and LNP formulation. No direct clinical trial results as they do not develop therapeutics themselves.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OZ Biosciences.